What is required in order for the manufacturer to be able to do the rework and sell the batch? For example, validation protocol, prior approval from FDA, annual report filing, supplement, etc.?

Aside from the filing issues, what you would rely on is extensive sampling and testing of that
reworked batch to assure that the rework batch is of equivalent quality. The rework would then be
conducted under concurrent validation under Q7A.